Skip to main content

Won Suk Lee

Yonsei University · 医学

研究室紹介

Professor Won Suk Lee's research lab specializes in translational cancer immunology and neuroinflammation, focusing on overcoming immunosuppressive tumor microenvironments and enhancing anti-tumor immunity. Key research directions include developing novel immunotherapies using TLR agonists and immune checkpoint inhibitors, investigating the role of tumor vasculature in T cell exclusion, and exploring natural compounds like anthocyanins for neuroprotective and anti-inflammatory effects in neurodegenerative diseases. The lab also integrates clinical decision support systems, such as IBM Watson for Oncology, to improve personalized cancer treatment planning.

cancer immunotherapytumor microenvironmentneuroinflammationimmune checkpoint inhibitorsTLR agonists

Research Overview

Papers
236
Total Citations
4,715
Papers (5y)
57
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
57total
2021
2022
2023
2024
2025
Citations per year (5y)
473total
20212022202320242025

Selected Papers

15
1
Review|665 citations·2020
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
Won Suk Lee, Hannah Yang, Hong Jae Chon, Chan Kim
SJR Q1Experimental & Molecular MedicineOA

Abstract Cancer immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced cancers. However, the tumor microenvironment (TME) functions as a formidable barrier that severely impairs the efficacy of ICIs. While the crosstalk between tumor vessels and immune cells determines the nature of anti-tumor immunity, it is skewed toward a destructive cycle in growing tumors. First, the disorganized tumor vessels hinder CD8 + T cell trafficking into the TME, disable

OncologyMedicine
2
Article|173 citations·2006
Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival
Won Suk Lee, Seong Hyeon Yun, Ho-Kyung Chun, Woo-Yong Lee, Hae‐Ran Yun, Jhingook Kim, Kwhanmien Kim, Young Mog Shim
SJR Q2International Journal of Colorectal Disease
HepatologyMedicine
3
Article|105 citations·2003
An anomaly intrusion detection method by clustering normal user behavior
Sang Hyun Oh, Won Suk Lee
SJR Q1Computers & Security
Computer Networks and CommunicationsComputer Science
4
Article|90 citations·2013
Anthocyanins Downregulate Lipopolysaccharide-Induced Inflammatory Responses in BV2 Microglial Cells by Suppressing the NF-κB and Akt/MAPKs Signaling Pathways
Jin‐Woo Jeong, Won Suk Lee, Sung Shin, Gi‐Young Kim, Byung Choi, Yung Choi
SJR Q1International Journal of Molecular SciencesOA

Anthocyanins are naturally occurring polyphenols that impart bright color to fruits, vegetables and plants and have a variety of protective properties, which have generally been attributed to their antioxidant capacity. However, little is known about the molecular mechanisms underlying anti-inflammatory effects of anthocyanins related to neurodegenerative diseases. Therefore, we determined whether anthocyanins isolated from black soybean seed coats would inhibit pro-inflammatory mediators and cy

NeurologyNeuroscience
5
Article|70 citations·2018
Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in Korea
Won Suk Lee, Sung‐Min Ahn, Jun‐Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoonjae Kim, S. Sym, Dongbok Shin, Inkeun Park, Uhn Lee, Jeong‐Heum Baek
SJR Q1JCO Clinical Cancer Informatics

PURPOSE: IBM Watson for Oncology (WFO) is a clinical decision-support computing system that provides oncologists with evidence-based treatment recommendations for a variety of cancer diagnoses. The evidence-based supported treatment recommendations are presented in three categories: Recommended, representing the Memorial Sloan Kettering Cancer Center (MSKCC) preferred approach; For Consideration, evidence-based alternative treatments; and Not Recommended, alternative therapies that may be unacce

Artificial IntelligenceComputer Science
6
Article|70 citations·2007
Treatment outcomes in patients with signet ring cell carcinoma of the colorectum
Won Suk Lee, Ho‐Kyung Chun, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Hae-Ran Yun, Sang-Hui Park, Sang Yong Song
SJR Q1The American Journal of Surgery
OncologyMedicine
7
Article|58 citations·2007
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis
Won Suk Lee, Min Jung Kim, Seong Hyeon Yun, Ho-Kyung Chun, Woo Yong Lee, Sung-Joo Kim, Seong‐Ho Choi, Jin-Seok Heo, Jae‐Won Joh, Yong Il Kim
SJR Q2Langenbeck s Archives of Surgery
HepatologyMedicine
8
Article|42 citations·2008
Treatment outcomes of hepatic and pulmonary metastases from colorectal carcinoma
Won Suk Lee, Hae‐Ran Yun, Seong‐Hyeon Yun, Ho‐Kyung Chun, Woo‐Yong Lee, Sungjoo Kim, Seong‐Ho Choi, Jin‐Seok Heo, Jae‐Won Joh, Y. Park, Won‐Ki Kang
SJR Q1Journal of Gastroenterology and Hepatology

BACKGROUND AND AIM: The resection of synchronous or metachronous pulmonary and liver metastasis is an aggressive treatment option for patients with stage IV colorectal cancer and has been shown to yield acceptable long-term survival. We reviewed our experience with colorectal cancer patients with both liver and lung resections to determine the efficacy of surgical resections. METHODS: We performed a single institution, retrospective analysis of all patients who underwent surgical hepatic and pul

HepatologyMedicine
9
Article|41 citations·2010
The prognostic significant of percentage drop in serum CEA post curative resection for colon cancer
Won Suk Lee, Jeong‐Heum Baek, Keon Kuk Kim, Yeon Ho Park
SJR Q1Surgical Oncology
Pulmonary and Respiratory MedicineMedicine
10
Article|36 citations·2012
Prognostic value of circulating cytokines for stage III colon cancer
Won Suk Lee, Jeong‐Heum Baek, Dong Hun You, Myeong Jin Nam
SJR Q1Journal of Surgical Research
OncologyMedicine
11
Article|36 citations·2022
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun‐Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Chan Kim
SJR Q1Journal for ImmunoTherapy of CancerOA

BACKGROUND: Toll-like receptors (TLRs) are critical innate immune sensors that elicit antitumor immune responses in cancer immunotherapy. Although a few TLR agonists have been approved for the treatment of patients with early-stage superficial cancers, their therapeutic efficacy is limited in patient with advanced invasive cancers. Here, we identified the therapeutic role of a TLR2/3 agonist, L-pampo (LP), which promotes antitumor immunity and enhances the immune checkpoint blockade. METHODS: We

ImmunologyImmunology and Microbiology
12
Article|30 citations·2014
The best candidates for nerve‐sparing stripping surgery for facial nerve schwannoma
Soon H. Park, Jin Kim, In Seok Moon, Won Suk Lee
SJR Q1The LaryngoscopeOA

OBJECTIVES/HYPOTHESIS: Clinical decision making for facial nerve schwannoma is particularly complicated in patients with good facial nerve function; however, an early nerve-sparing tumor resection stripping technique minimizes facial deficits associated with treatment. The present study characterized the optimal candidate for this nerve-sparing surgical strategy in patients with good facial function. STUDY DESIGN: Retrospective study. METHODS: Nerve-sparing stripping surgery was performed on 28

NeurologyMedicine
13
Article|30 citations·2007
Cell trees: An adaptive synopsis structure for clustering multi-dimensional on-line data streams
Nam Hun Park, Won Suk Lee
SJR Q2Data & Knowledge Engineering
Artificial IntelligenceComputer Science
14
Article|29 citations·2014
CP-tree: An adaptive synopsis structure for compressing frequent itemsets over online data streams
Se Jung Shin, Dae Su Lee, Won Suk Lee
SJR Q1Information Sciences
Information SystemsComputer Science
15
Article|27 citations·2009
En bloc Resection for Right Colon Cancer Directly Invading Duodenum or Pancreatic Head
Won Suk Lee, Woo Yong Lee, Ho-Kyung Chun, Seong‐Ho Choi
SJR Q2Yonsei Medical JournalOA

In patients with locally advanced right side colon cancer that directly invades the duodenum or pancreas can be safely resected with curative potential with minimum morbidity and mortality. Long term disease free survival can occur in a significant number of patients undergoing curative en bloc resection in this particular subset of patients.

Pulmonary and Respiratory MedicineMedicine

Research Areas

OncologyComputer Networks and CommunicationsInformation SystemsHepatologyImmunologyArtificial Intelligence

Won Suk Leeの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。